Biopharmaceutical Development Services | Charles River

regulatory compliance 

We understand your need to develop a biopharmaceutical product that meets the rigorous requirements of global regulatory bodies.  Charles River BPS has provided guidance to biotech companies on CMC Regulatory Compliance for biopharmaceuticals.  With more than 90 years of combined experience with the FDA, EMEA and MLHW agencies, BPS’ technical and quality assurance personnel can accelerate the development of your biological to meet regulatory compliance in the GMP/GLP testing and manufacturing environment.  

Regulatory Compliance Standards

  • Compendial Methods to meet Pharmacopeia Requirements
  • Q7A
  • Q5A
  • Q5C
  • Q5D
  • Q2 (R1)
  • 21 CFR 11, 210, 211, 58, 610, and 611
  • Eudralex
  • Aseptic processing

 

General Compliance Audit History

  • 13 FDA inspections since 1993
  • Routinely audited by domestic and international clients for GMP, GLP, and Q7A compliance
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

(Country Code)+800.3195.3430
askcharlesriver@crl.com

view all

News & Events

view all
mai 14 - New Models for Evaluating COPD or ...
mai 11 - Expert Safety Testing to Accelerat...
juin 14-juin 14 - Hørsholm, Denmark - Biotech Outsourcing Strategies (chemistry, manufa...
juin 02-juin 05 - Vancouver, British Columbia - CALAS
juin 05-juin 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Bi...
juin 05-juin 08 - Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA, US

Charles River Laboratories, Inc.